We have studied the effects of D-threo-l-phenyl-2-decanoylamino-3-morpholino-l-propanol (D-PDMP) and its Lenantiomer on glycosphingolipids in cultured normal human kidney proximal tubular cells. We found that D-PDMP exerted a concentration-dependent reduction in the metabolic labelling and cellular levels of glucosylceramide (GlcCer), lactosylceramide (LacCer), and the globo-series glycosphingolipids, GbOse3Cer and GbOse4Cer. It also directly inhibited the activity of UDP-glucose:ceramide /31 ---> 4-glucosyltransferase (GlcT-1) and UDP-galactose: GlcCer /31 ---> 4 galactosyltransferase (GAIT-2). In contrast, L-PDMP had opposite effects on the metabolic labelling of GlcCer, LacCer, and GbOse3Cer. The levels of GlcCer and LacCer were increased, while the labelling and level of GbOse4Cer were strongly reduced. Purified GalT-2 from human kidney was inhibited by D-PDMP and stimulated by L-PDMR It appears likely that the different glycosphingolipid glycosyltransferases possess similar binding sites for the ceramide moiety, which are blocked by binding to D-PDMP and, in the case of GbOse4Cer synthase, by L-PDMP as well. The stimulatory effects of L-PDMP on GtcCer and LacCer synthases may be the result of binding to a modulatory site on the glycosyltransferases; in intact cells, the enzyme-analog complex may afford protection against the normal catabolic inactivation of the enzymes.
Introduction
Glycosphingolipids (GSLs) are complex sugar-containing sphingolipids. Recently, these compounds have drawn increased attention because of their possible functional roles in cell proliferation, cell differentiation and pro-*To whom correspondence should be addressed.
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Chapman & Hall grammed cell death [1] [2] [3] . GSLs are composed of a sphingol (a long-chain sphingoid base), a fatty acid, and a simple or complex carbohydrate moiety. The hydrophobic moiety of GSLs, ceramide, is composed of the sphingol substituted at its amino group by a fatty acid in amide linkage. The sequential transfer of carbohydrate moieties from nucleotide sugars to ceramide gives rise to GSLs [4] . For example, the transfer of glucose from UDP-glucose to ceramide gives rise to glucosylceramide (GlcCer), which serves as the base for several hundred GSLs. The enzyme that catalyzes this transfer is termed GlcT-1. The enzyme that transfers galactose from UDP-galactose to GlcCer to produce tactosylceramide (LacCer) is termed GalT-2. Our laboratory has reported the purification of GalT-2 from human kidney [5] .
Both GlcCer and LacCer have been shown to induce proliferation in a variety of cells [1, 6] . For example, the effects of GlcCer on the proliferation of a continuous cell line, MDCK, have been shown [6] . GlcCer enhanced epidermal proliferation [7] and, in intact mice, liver proliferation [8] . Previously we showed that, besides these two simple GSLs, other GSLs either moderately stimulated the proliferation of aortic smooth muscle cells or did not stimulate proliferation at all [I] . Most of the gangliosides investigated in our previous study did not stimulate the proliferation of cells, rather they caused a decrease in proliferation, possibly because they inhibit the biosynthesis of GlcCer [9] .
Other studies have shown the reverse effect: reduction of cell growth and levels of GlcCer and LacCer by using a synthetic inhibitor of GSL biosynthesis [1, 6] . Properties of the inhibitor, D-PDMP, have been reviewed recently [10, 11] . From kinetic data, it appears that the compound binds to a region near the UDP-glucosebinding site and to a second site that acts like an activity modulator.
L-PDMP, on the other hand, stimulated the proliferation of cultured aortic smooth muscle cells [I] . It was also found to increase the level of LacCer in B 16 melanoma cells [12, 13] . Taken together, these findings suggest that LacCer, GicCer or a derivative o f these compounds is involved in the proliferation of normal cells and of cells participating in proliferative diseases, such as atherosclerosis, cancer, and polycystic kidney disease [1, 14] . In this paper, we have used both enantiomeric forms of PDMP to investigate the biochemical mechanisms of action of these ceramide analogs on the activities of GlcT-1 and GalT-2 in cultured human proximal tubular cells. 
Materials and methods

Isotopes and chemicals
Cell culture
Normal proximal tubule cells were prepared from human kidney. Cells (10 5) were seeded in plastic Petri dishes (8 cm diam.) in 10 ml of medium containing 10% fetal bovine serum. The medium was changed on the third day. On the sixth das; the medium was removed and fresh medium containing lipoprotein-deficient human serum (1 mg of protein per ml) plus D-PDMP or L-PDMP was added as described in the figures and legends. The lipoprotein-deficient serum was used because whole serum stimulates GSL synthesis.
One set of dishes was incubated with [3H]galactose (5 gCim1-1) for 24 h and harvested. These radiolabelled cells were used to investigate the incorporation of galactose into GSLs as described previously [15] . A second set of cells, incubated with or without D-or L-PDMP for 24h, was harvested in phosphate-buffered saline and centrifuged. The cell pellets were utilized for the measurements of GSLs levels following extraction, purification, perbenzoylation and high performance liquid chromatography [16] . The third set of cells was harvested in cacodylate buffer (pH 6.8) as described [4] , and the cell extracts were then utilized for the measurement of activity of GlcT-1 and GalT-2 after a 2-h incubation as described [17] .
Three dishes were pooled for each analysis and at least nine dishes were used for each variable tested. The error bars in each figure represent the standard deviation of each group.
Results
Effects of D-and L-PDMP on the incorporation of [3H]galactose into GSLs
We found that D-PDMP exerted a concentration-dependent inhibition of the incorporation of [3It]galactose into GlcCer (Fig. 1A) . The effect became noticeable at 5 gM inhibitor. D-PDMP also markedly reduced the incorporation of [3H]galactose into LacCer, GbOse3Cer, and GbOse4Cer (Fig. 1B-D) . The latter decreases can be attributed, in part at least, to depleted levels of their precursor, GlcCer. However the decreases were seen with 2.5 glvI PDMR which did not affect GlcCer radioactivity, suggesting the possibility of direct influences of D-PDMP on the synthases that forrn the higher GSLs, such as GalT-2.
In contrast, L-PDMP stimulated the incorporation of [3H]galactose into GlcCer, LacCer and globotriaosylceramide (Fig. 1A-C tion of [3HI into LacCer and GbOse3Cer were even greater, and dose-dependent (Fig. 1B, C) . Thus the possibility is raised that L-PDMP stimulated the synthases forming LacCer and GbOse3Cer, in addition to GlcCer synthase. In a striking demonstration of the specificity of L-PDMP action, the compound produced a marked decrease in the incorporation of [3H]galactose into GbOse4Cer, even at 2.5 ~tM (Fig. 1D) . We may speculate that the L-isomer acts to directly inhibit the Nacetylgalactosaminyltransferase that forms GbOse4Cer.
The same can be said for D-PDMt~ which also strongly inhibited the incorporation of [3H]-Gal into GbOse4Cer, more so than into its precursor.
Effects of D-PDMP and L-PDMP on the cellular levels of GSLs
D-PDMP produced marked decreases in the concentrations of GtcCer, LacCer, GbOse3Cer, and GbOse4Cer. Such decreases in GlcCer and LacCer have previously been seen in a variety of cell types and they are evidently due, in part at least, to depletion of GlcCer stores by the direct inhibitory action of D-PDMP on GtcCer synthase. Presumably all the GSLs are in a dynamic state, undergoing hydrolysis as well as synthesis; thus they decrease in concentration as the supply of GlcCer decreases. The decreases in GbOse3Cer and GbOse4Cer have not been reported before. The most remarkable effect of D-PDMP was on the cellular levels of GbOse3Cer, acting at concentrations <2.5 gM. This difference suggests that D-PDMP directly ~inhibits GbOse3Cer synthase.
As might be expected from L-PDMP's effects on [3H]galactose incorporation into the GSLs (Fig. 1) , the ceramide analogue markedly stimulated the cellular levels of GlcCer, LacCer and (to a small extent) GbOse3Cer, but reduced the cellular levels of GbOse4Cer (Fig. 2) . Chatterjee et al.
The cellular level of GtcCer was increased approximately 100% with 10 gM L-PDMR At higher concentrations, the levels of GlcCer were decreased but still about 60% higher than the control value. At higher concentrations (20gM), the stimulatory actions of L-PDMP were lessened, suggesting the possibility that the compound acts at two sites, one stimulatory, the other inhibitory.
Effects of L-and D-PDMP on the activity of GlcT-t and GatT-2 in celt extracts
D-PDMP exerted a concentration-dependent inhibition of the specific activity of GlcT-1 in the crude extracts from normal cells (Fig. 3A) . Distinct inhibition was seen at 2.5 gM inhibitor and the activity was decreased to about 30% of normal at 10 gM. This observation adds normal human kidney cells to the list of cells whose GlcT-1 is directly inhibited by PDMP. L-PDMP stimulated the activity of Glc%l in these cell extracts, in agreement with our observations o f [3H] incorporation and cell GlcCer levels. We found that D-PDMP also decreased the activity of GaiT-2 in these enzyme preparations (Fig. 3B) , although the effect was weaker than that seen with GlcT-1. On the other hand, L-PDMP markedly stimulated the activity of GalT-2, the effect being stronger than that seen with GlcT-1. The maximal stimulation, at 10btM, was 80% above the control activity.
Effects olD-and L-PDMP on purified GalT-2 from human kidney
Evidence that the above-described effects of PDMP on purified GalT-2 in broken cell preparations represented direct action on the enzyme (rather than indirect effects involving other cell components) was obtained by tests with purified GalT-2. We found that D-PDMP strongly (Fig. 3C) . The use of higher D-PDMP concentrations did not lower the activity any further.
In contrast, L-PDMP markedly stimulated the activity of GaiT-2 in the purified preparation. Here too the effect was visible at a low concentration. However, at higher concentrations (10-20 gM) L-PDMP acted as an inhibitor, again indicating opposing actions at two different enzyme sites (Fig. 3c) .
Discussion
This study revealed several major findings. D-PDMR initially thought to inhibit only GlcCer synthase, was found to directly inhibit LacCer synthase (GAIT-2). Suggestive evidence was also found for a direct inhibitory action on the two globo-series synthases. These effects are in agreement with recent data from the Inokuchi laboratory [13] , which found direct inhibition in B16 melanoma cells of GlcT-1, GalT-2, and the sialyltransferase that converts LacCer to ganglioside GM3. This rather general inhibitory action of D-PDMP is probably due to the presence of a similar binding site common to all these enzymes. At the present time we can only speculate that the ceramide-binding site, probably underwent little evolutionary mutation during the development of GSLs with more complex structures. The enzymes forming more complex GSLs, such as the ganglioside synthases, probably appeared later in evolutionary history, so their ceramide-binding regions may have mutated to regions that bind D-PDMP more weakly. The essential role of ceramide moiety in GalT-3 a galactosyltransferase that catalyzes the transfer of galactose form GM2 to GM1 has been reported [18] . This hypothesis raises the possibility that analogs of PDMP could be synthesized with more specific ability to inhibit the more complex synthases. Several new analogues have recently been described [19] ; some of them are much more inhibitory against GlcT-1 and it will be interesting to compare the enantiomeric forms against the higher glycosyltransferases.
The stimulatory actions of L-PDMP reported here are consistent with the report that it increased the level of GIcT-1, GalT-2, and LacCer sialyltransferase in melanoma cells [13] . However those effects could be demonstrated only in growing cells, not in cell lysates, and it would appear that the phenomenon involved was inductive in nature. Culturing cells exposed to cycloheximide caused them to lose most of their GalT-2 activity, indicating that this enzyme normally undergoes rapid synthesis and inactivation. In the presence of L-PDMR however, the loss of enzyme was not as great. This may signify that L-PDMP binds to the enzyme, stabilizing it against the normal catabolic inactivation process. In the case of our purified GalT-2, the stimulation by L-PDMP was direct, not inductive.
The especially strong reduction in synthesis of the globo-series GSLs reported in our study raises the possibility that a mixture of D-and L-PDMP would be particularly effective in blocking the binding of various pathogenic organisms [20, 21] . These organisms must bind to globoside-bearing sites on human and porcine cells in order to produce their toxic actions. DL-PDMP has been shown to successfully block such binding between E. coli and human kidney and intestine cells in vitro [22] . Certain human tumours have also been shown to be enriched in globosides and it is possible that they are particularly sensitive to DL-PDMR
